MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mukka Proteins Limited reported robust FY26 consolidated results with revenue surging 44% YoY to ₹1,449.5 crore, driven by strong global fishmeal demand and improved pricing. EBITDA grew 30.9% to ₹145.3 crore while PAT rose 18.7% to ₹57.1 crore. Despite topline growth, EBITDA margin contracted to 10.0% from 11.0% and PAT margin fell to 3.9% from 4.8% due to input cost pressures. Q4 FY26 showed strong profitability expansion with EBITDA margin improving 421 bps YoY to 12.9%. The company received MarinTrust Improver Programme certification, approved an Oman manufacturing facility (21,249 sq mt), incorporated Lanka Bio Proteins for Sri Lanka expansion, and secured a Bengaluru waste management contract from BBMP/BSWML.
Strong topline growth of 44% YoY reflects favorable industry dynamics and operational execution, though margin compression warrants monitoring. International expansion and sustainability certifications enhance long-term growth prospects and global competitiveness.